Human lncRNA, biological material for inhibition, preparation and application

CN120098996APending Publication Date: 2025-06-06NANJING MATERNITY & CHILD HEALTH CARE HOSPITAL +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510139563.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-02-08
Publication Date
2025-06-06

Smart Images

  • Figure HDA0005264366770000011
    Figure HDA0005264366770000011
  • Figure HDA0005264366770000012
    Figure HDA0005264366770000012
  • Figure HDA0005264366770000013
    Figure HDA0005264366770000013
Patent Text Reader

Abstract

The invention discloses a human lncRNA, a biological material for inhibition, a preparation and application, the human lncRNA is derived from a human chromosome Chr8p21.3 and has a nucleotide sequence as shown in SEQ ID NO.1, the biological material for inhibition and the preparation provided by the invention can effectively inhibit the expression of the lncRNA so as to inhibit adipocyte differentiation, and the human lncRNA can be used for inhibiting adipocyte differentiation. Comprising inhibition of expression quantities of differentiation related genes C / EBP alpha, C / EBP beta and FABP4 and inhibition of formation of lipid droplets. Furthermore, a biological material and a preparation for inhibiting the human lncRNA can be used for preparing medicines for treating obesity, and a new direction is provided for obesity intervention.
Need to check novelty before this filing date? Find Prior Art